Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-05-20

Clinical Trial Update: Plasma Glucose Levels With Dexamethasone as Adjuvant to Interscalene Block [Phase 3]

View source ↗

Summary

Trial NCT01538459, assessing whether dexamethasone as an adjuvant to interscalene nerve block affects plasma glucose in patients with shoulder pain/injury, has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Lifespan | Conditions: Shoulder Pain, Injury of Shoulder Region | Phase 3 | Status: WITHDRAWN